personalized medicine - debunking the myths

15
Debunking the Myths

Upload: conversant-biologics-inc

Post on 11-Apr-2017

315 views

Category:

Health & Medicine


3 download

TRANSCRIPT

Debunking the Myths

BACKGROUND INFORMATION

What is personalized medicine?

o Pharmacogenomics is part of a field called personalized medicine — also called

individualized or precision medicine — that aims to customize health care, with decisions

and treatments tailored to each individual patient in every way possible.

o Although genomic testing is still a relatively new development in drug treatment, this field is

expanding.

o Currently, more than 100 drugs have label information regarding pharmacogenomic

biomarkers — some measurable or identifiable segment of genetic information that can be

used to direct the use of a drug. [2]

What is

personalized

medicine?

o Different people respond differently to the same

therapy: while one treatment brings about the

desired success in one group of patients with e.g.

colon cancer, it does not change the condition of

other groups at all, or even leads to adverse

effects (left).

o The reason: the genetic makeup and metabolic

profile of each individual patient influences the

effect of a drug.

o Personalized medicine takes these individual

patterns of cellular and metabolic products into

account in the diagnostic phase: biomarker

diagnostics separates the patients into groups

with similar characteristics, and provides

information on the best individual treatment. This

should enable patients to benefit from their own,

“personal” therapy. Bayer Healthcare

Why do we use

personalized

medicine?

o Personalized medicine can be used to learn about a person's genetic makeup and to unravel the biology of their tumor.

o Using this information, doctors hope to identify prevention, screening, and treatment strategies that may be more effective and cause fewer side effects than would be expected with standard treatments.

o By performing more genetic tests and analysis, doctors may customize treatment to each patient's needs. [3]

MYTHS DEBUNKED

Let’s get the facts straight!

All tumors are the same.

We once thought that cancer was one disease. Now we know that there are many types

of cancer.

Advances in science have shown that a tumor’s makeup (including genes) can vary

greatly.

Even tumors from the same part of the body, such as the breast, are not all the same.

For example, there is thought to be as many as five different kinds of female breast

cancer, depending on the genetic makeup of the tumor. This may explain why a

treatment might work for one person but not another.

MYTH:

FACTS

[1]

Personalized medicine will only be helpful in the

future.

Biomarkers have already been identified for many types of cancers.

These include breast, colorectal, lung, and prostate cancers, among other tumor types.

Today, they are being used to show a person’s risk for developing cancer, to diagnose the

disease or to guide treatment decisions.

The information in these biomarkers may help the doctor know if a treatment may be

more or less likely to work, or if the cancer might come back, or recur.

Researchers continue to find more biomarkers, making personalized medicine a reality in

more cancers.

MYTH:

FACTS

[1]

Personalized medicine means there will be a

treatment made specifically for me.

Personalized medicine aims to find the right treatment for the right patient, but does not

mean that treatments are created for each patient.

In many cases, doctors can use information about a person’s or a tumor’s genes and

proteins to prevent, diagnose, and treat disease.

Some cancer tumors have special cells, genes, or proteins called biomarkers.

These biomarkers can give doctors information used to determine what treatment options

may be more or less likely to work for the specific type of cancer the patient has.

MYTH:

FACTS

[1]

Biomarker testing is only done at the time of a

diagnosis.

Biomarker testing can happen at any time during your diagnosis or treatment.

A doctor may say the right time is after you have been diagnosed, but before you start

treatment.

That way, the test may help the doctor find a treatment that may be best suited for your

type of tumor. If you have already begun treatment, then your doctor might test the

original tumor sample.

This might inform treatment decisions in the next round of therapy. In some cases, doctors

may need to take another sample of your tumor tissue.

MYTH:

FACTS

[1]

If my test results don’t show I have a biomarker, then

personalized medicine is not an option for me.

If test results do not show a biomarker, your doctor may be able to narrow down

treatment options.

The result may still help a doctor know if a certain treatment is likely to work and whether it

should be used.

In some cases, the doctor may try testing for a different biomarker. Keep in mind that, in

some cases, while biomarker testing can help guide treatment, it is not the only way. And

it may not always be the right approach for every patient.

Your doctor can determine if biomarker testing is right for you.

MYTH:

FACTS

[1]

If I am a candidate for personalized medicine and

targeted therapy, then only my cancer cells will be

touched and I won’t feel any side effects.

The goal of targeted therapy is to target tumor-specific pathways and try to stop cancer

cells from growing.

That doesn’t mean that healthy cells will never be touched.

There are side effects to any medication, and every person reacts differently to treatment.

The goal of personalized medicine is to help doctors choose a treatment that is more likely

to benefit the patient.

MYTH:

FACTS

[1]

Doctors make all the decisions related to cancer

treatment.

There are many people involved in making treatment decisions.

As a patient, you play a key role. You should learn all you can about your cancer and

tumor type.

That way, you can be better informed when you work with your doctors to create a plan

that is best for you.

MYTH:

FACTS

[1]

How You Can Help

According to the National Cancer Institute, “the lack of highly characterized biospecimens is the #1 barrier to

the advancement of new therapies.”

Conversant Bio gives patients a way to help fight

their disease, and their doctors a way to advance

pre-clinical disease research.

Contact Us

Conversant Healthcare Systems, Inc. (Conversant Bio)

Take Your Research Further. Faster.

601 Genome Way, Suite 1200

Huntsville, AL 35806

(866) 838-2798 phone

(256) 705-4103 fax

www.conversantbio.com

To find out more about Conversant Bio, email us at

[email protected]

The Conversant Bio Advantage• Quality Control System

• In-House Lab

• Fast Processing

• Diverse and Advanced Equipment

• Experienced Researchers and Staff